{"company_id": "companyB", "docset": "CompanyB_-_SHA_Amendment_2025-02", "doc_type": "SHA", "clause_family": "veto", "items": [{"item_id": "companyB_sha_veto_it001", "present": false, "clause_type": "veto (unspecified)", "beneficiary": "unclear", "trigger": "", "effect": "", "thresholds": null, "evidence": {"quote": "", "source_file": "", "page": null, "article": null}, "confidence": 0.36, "flags": ["missing_evidence"]}]}
{"company_id": "companyB", "docset": "CompanyB_-_SHA_Amendment_2025-02", "doc_type": "SHA", "clause_family": "liquidity", "items": [{"item_id": "companyB_sha_liquidity_it001", "present": true, "clause_type": "Transfer restrictions", "beneficiary": "investor", "trigger": "Proposed transfer of shares", "effect": "Restricts transfers or grants ROFR/approval right", "thresholds": "20 Business Days", "evidence": {"quote": "Toute cession de titres à un tiers est soumise à agrément préalable, sous réserve des transferts autorisés.", "source_file": "CompanyB_SHA_Amendment_2025-02.pdf", "page": 3, "article": "11"}, "confidence": 0.84, "flags": []}]}
{"company_id": "companyB", "docset": "CompanyB_-_SHA_Amendment_2025-02", "doc_type": "SHA", "clause_family": "exit", "items": [{"item_id": "companyB_sha_exit_it001", "present": false, "clause_type": "exit (unspecified)", "beneficiary": "unclear", "trigger": "", "effect": "", "thresholds": null, "evidence": {"quote": "", "source_file": "", "page": null, "article": null}, "confidence": 0.28, "flags": ["missing_evidence"]}]}
{"company_id": "companyB", "docset": "CompanyB_-_SHA_Amendment_2025-02", "doc_type": "SHA", "clause_family": "anti_dilution", "items": [{"item_id": "companyB_sha_anti_dilution_it001", "present": false, "clause_type": "anti_dilution (unspecified)", "beneficiary": "unclear", "trigger": "", "effect": "", "thresholds": null, "evidence": {"quote": "", "source_file": "", "page": null, "article": null}, "confidence": 0.17, "flags": ["missing_evidence"]}]}
